DART Study: A phase II randomized trial of dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma (RCC): Results from Part 1
Voss, Martin Henner, Plimack, Elizabeth R., Rini, Brian I., Atkins, Michael B., Alter, Robert, Bhatt, Rupal Satish, Beck, J. Thaddeus, Pappas, Kristen M., Wilson, Dawn, Zhang, Xiaosha, Sherman, Matthew L., Pandya, Shuchi Sumant
Published in Journal of clinical oncology (01.03.2015)
Published in Journal of clinical oncology (01.03.2015)
Get full text
Journal Article
Rates of occult brain metastases in patients (pts) with advanced renal cell carcinoma (RCC): A cohort study from patients treated across 22 clinical trials
Kotecha, Ritesh, Redzematovic, Almedina, Motzer, Robert J., Voss, Martin Henner
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Comparative genomic profiling from tumor tissue and circulating tumor DNA (ctDNA) in 111 patients (Pts) with metastatic clear cell renal cell carcinoma
Kotecha, Ritesh, Gedvilaite, Erika, Murray, Samuel J., Motzer, Robert J., Tsui, Dana, Voss, Martin Henner
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Baseline lactate dehydrogenase (LDH) and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with everolimus (EVE) versus sunitinib (SUN): Predictive biomarker analysis from the RECORD-3 trial
Voss, Martin Henner, Chen, David, Marker, Mahtab, Knox, Jennifer, Hsieh, James, Voi, Maurizio, Motzer, Robert J.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Dynamics of immune-mediated thyroid dysfunction in patients with advanced renal cell carcinoma receiving checkpoint inhibitor therapy
Osorio, Juan Carlos, Patil, Sujata, Coskey, Devyn Taylor, Carlo, Maria Isabel, Feldman, Darren R., Hellmann, Matthew David, Voss, Martin Henner
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant
Ged, Yasser, Knezevic, Andrea, Chen, Yingbei, Redzematovic, Almedina, Carlo, Maria Isabel, Lee, Chung-Han, Feldman, Darren R., Patil, Sujata, Motzer, Robert J., Voss, Martin Henner
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Characterizing tumor immune microenvironment (TME) and outcomes for 409 patients (pts) treated on COMPARZ: Distinct clusters emphasize immune infiltration vs. angiogenesis
Voss, Martin Henner, Kuo, Fengshen, Sanchez, Alejandro, Ostrovnaya, Irina, Cheng, Yuan, Patel, Parul, Marker, Mahtab, Reising, Albert, Chan, Timothy An-thy, Motzer, Robert J., Hakimi, A. Ari
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Tumor genomic analysis for 128 renal cell carcinoma (RCC) patients receiving first-line everolimus: Correlation between outcome and mutations status in MTOR, TSC1, and TSC2
Voss, Martin Henner, Chen, David, Marker, Mahtab, Xu, Jianing, Patel, Parul, Han, Xia, Hsieh, James, Motzer, Robert J.
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Incorporation of PBRM1 , BAP1 , TP53 mutation status into the Memorial Sloan Kettering Cancer Center (MSKCC) risk model: A genomically annotated tool to improve stratification of patients (pts) with advanced renal cell carcinoma (RCC)
Voss, Martin Henner, Cheng, Yuan, Marker, Mahtab, Kuo, Fengshen, Choueiri, Toni K., Hsieh, James J, Reising, Albert, Motzer, Robert J., Hakimi, A. Ari
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)
Ged, Yasser, Knezevic, Andrea, Chen, Yingbei, Redzematovic, Almedina, Carlo, Maria Isabel, Lee, Chung-Han, Feldman, Darren R., Patil, Sujata, Motzer, Robert J., Voss, Martin Henner
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)
Ged, Yasser, Gupta, Ruby, Duzgol, Cihan, Shapnik, Natalie, Redzematovic, Almedina, Kotecha, Ritesh, Voss, Martin Henner, Feldman, Darren R., Akin, Oguz, Patil, Sujata, Motzer, Robert J., Rini, Brian I., Lee, Chung-Han
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
Ged, Yasser, Lee, Chung-Han, Sanchez, Alejandro, Duzgol, Cihan, Chaim, Joshua, Carlo, Maria Isabel, Foster, Ashley, Akin, Oguz, Feldman, Darren R., Hakimi, A. Ari, Patil, Sujata, Motzer, Robert J., Furberg, Helena, Voss, Martin Henner
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
The impact of PBRM1 mutations on overall survival in greater than 2,100 patients treated with immune checkpoint blockade (ICB)
Hakimi, A. Ari, Ged, Yasser, Flynn, Jessica, Hoen, Douglas R, Di Natale, Renzo G, Blum, Kyle A, Makarov, Vladimir, Kuo, Fengshen, Carlo, Maria Isabel, Lee, Chung-Han, Voss, Martin Henner, Ostrovnaya, Irina, Chan, Timothy An-thy, Motzer, Robert J.
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors
Shah, Amishi Yogesh, Kotecha, Ritesh, Lemke, Emily, Chandramohan, Anuradha, Chaim, Joshua, Msaouel, Pavlos, Xiao, Lianchun, Gao, Jianjun, Campbell, Matthew T, Zurita, Amado J., Wang, Jennifer, Corn, Paul Gettys, Jonasch, Eric, Motzer, Robert J., Sharma, Padmanee, Voss, Martin Henner, Tannir, Nizar M.
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (IO) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
Ged, Yasser, Chaim, Joshua, Knezevic, Andrea, Carlo, Maria Isabel, Foster, Ashley, Feldman, Darren R., Teo, Min Yuen, Riaz, Nadeem, Lee, Chung-Han, Patil, Sujata, Chan, Timothy An-thy, Hakimi, A. Ari, Motzer, Robert J., Voss, Martin Henner
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Genomic biomarkers of response to nivolumab/ipilimumab (nivo/ipi) and nivolumab (nivo) monotherapy in 108 patients with advanced renal cell carcinoma
Lee, Chung-Han, Di Natale, Renzo G, Chowell, Diego, Makarov, Vladimir, Redzematovic, Almedina, Murray, Samuel J., Carlo, Maria Isabel, Voss, Martin Henner, Feldman, Darren R., Motzer, Robert J., Chan, Timothy An-thy, Hakimi, A. Ari
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
A phase I/II study to assess the safety and efficacy of pazopanib (PAZ) and pembrolizumab (PEM) in patients (pts) with advanced renal cell carcinoma (aRCC)
Chowdhury, Simon, McDermott, David F., Voss, Martin Henner, Hawkins, Robert E., Aimone, Paola, Voi, Maurizio, Isabelle, Naëije, Wu, Yi, Infante, Jeffrey R.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
The genomic landscape of metastatic non-clear cell renal cell carcinoma
Carlo, Maria Isabel, Khan, Nabeela, Chen, Yingbei, Hsieh, James, Hakimi, A. Ari, Lee, Chung-Han, Feldman, Darren R., Motzer, Robert J., Voss, Martin Henner
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Genomic alterations to refine prognostication of patients with metastatic renal cell carcinoma
Bosse, Dominick, Xie, Wanling, Lalani, Aly-Khan A., de Velasco, Guillermo, Voss, Martin Henner, Tannir, Nizar M., Tamboli, Pheroze, Appleman, Leonard Joseph, Rathmell, Kimryn, Heng, Daniel Yick Chin, Sonpavde, Guru, Signoretti, Sabina, Hakimi, A. Ari, Choueiri, Toni K.
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
Safety and efficacy of the selective FGFR inhibitor debio 1347 in phase I study patients with FGFR genomically activated advanced biliary tract cancer (BTC)
Cleary, James M., Voss, Martin Henner, Meric-Bernstam, Funda, Hierro, Cinta, Heist, Rebecca Suk, Ishii, Nobuya, Kirpicheva, Yulia, Nicolas-Metral, Valerie, Pokorska-Bocci, Anna, Vaslin, Anne, Venetz, Werner, Zanna, Claudio, Flaherty, Keith, Tabernero, Josep, Baselga, Jose
Published in Journal of clinical oncology (01.02.2018)
Published in Journal of clinical oncology (01.02.2018)
Get full text
Journal Article